Multiple Sclerosis and Chronic Fatigue
Multiple sclerosis (MS) is a chronic, immune-mediated demyelinating disease of the central nervous system. Fatigue—often described as an overwhelming lack of physical and/or mental energy—is among its most common and disabling symptoms, affecting daily function, work capacity, and quality of life. Chronic fatigue, as a clinical problem, can be primary (central) due to neuroinflammatory and neurodegenerative mechanisms or secondary to comorbid conditions (sleep disorders, depression/anxiety, endocrine or hematologic issues), medications, deconditioning, or environmental factors such as heat. In MS, both primary and secondary drivers frequently coexist, which is why structured assessment and multimodal management are essential. Prevalence estimates indicate 75–90% of people with MS experience fatigue, with roughly half reporting moderate-to-severe or disabling fatigue. Neuroinflammation, disruption of large-scale brain networks, impaired cortico-striatal-thalamic connectivity, autonomic dysregulation, and possible mitochondrial dysfunction can generate central fatigue. Sleep fragmentation (e.g., due to nocturia, spasticity, pain), sleep apnea, circadian disturbance, mood disorders, and adverse drug effects commonly amplify fatigue severity. Viral illnesses (e.g., EBV history in MS; other post-viral states) may also shape vulnerability to persistent fatigue. Evidence-based management begins with identifying and treating secondary contributors: screen for sleep apnea or insomnia, depression/anxiety, thyroid dysfunction, iron or B12 deficiency, medication side effects, and pain or spasticity. Nonpharmacologic strategies have the strongest and broadest support in MS-related fatigue: individualized energy conservation and pacing, activity management and physical rehabilitation, exercise training adapted to disability level, cooling strategies for heat sensitivity, cognitive-behavioral therapy (CBT) including CBT for insomnia, and occupational therapy. Pharmacologic aid
Updated April 15, 2026This content is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before starting, stopping, or changing any supplement or medication regimen.
Shared Risk Factors
Female sex
Strong EvidenceBoth MS and chronic fatigue presentations are more common in women, potentially reflecting immunoendocrine differences and care-seeking patterns.
Viral infection history (notably EBV)
Strong EvidenceEBV is a near-ubiquitous antecedent and strong risk factor for MS; viral illnesses can trigger or perpetuate chronic fatigue states.
Sleep disorders (insomnia, sleep apnea, restless legs)
Strong EvidenceSleep fragmentation and nonrestorative sleep drive daytime fatigue and cognitive fog.
Depression and anxiety
Strong EvidenceA bidirectional relationship exists between mood disorders and fatigue via behavioral, neurochemical, and sleep pathways.
Physical inactivity and deconditioning
Moderate EvidenceReduced activity lowers fitness and worsens exertional fatigability.
Vitamin D insufficiency/low sun exposure
Emerging ResearchLow vitamin D is linked to MS risk and activity; associations with fatigue are reported though causality is uncertain.
Smoking
Moderate EvidenceSmoking increases MS risk and disease progression; also worsens sleep and fatigue.
Medication effects
Strong EvidenceCNS depressants (antispasmodics, sedatives, anticholinergics) and polypharmacy can cause or worsen fatigue.
Comorbidity Data
Prevalence
Fatigue occurs in about 75–90% of people with MS; approximately 40–60% report clinically significant or disabling fatigue. Formal co-diagnosis with chronic fatigue syndrome (ME/CFS) is uncommon and not well quantified.
Mechanistic Link
Central neuroinflammation, demyelination, axonal loss, and network disconnection in MS produce primary (central) fatigue; secondary pathways include sleep disruption, pain, mood disorders, autonomic dysfunction, endocrine and hematologic abnormalities, medication effects, and heat sensitivity. Shared inflammatory and neuroendocrine mechanisms connect MS-related fatigue to chronic fatigue states more broadly.
Clinical Implications
Always screen MS patients with fatigue for secondary, treatable causes (sleep apnea/insomnia, depression/anxiety, hypothyroidism, iron/B12 deficiency, adverse drug effects). Combine energy conservation, tailored physical rehabilitation/exercise, CBT/CBT-I, cooling, and occupational therapy. Consider cautious pharmacologic trials (e.g., amantadine) when nonpharmacologic steps are optimized; monitor benefit and side effects closely.
Sources (3)
- National MS Society. Fatigue in MS (accessed 2024).
- Penner IK, Paul F. Fatigue in multiple sclerosis: pathophysiology and management. Nat Rev Neurol. 2017.
- MS Society UK. Fatigue (accessed 2024).
Overlapping Treatments
Screening and correction of secondary causes
Strong EvidenceImproves MS-related fatigue by addressing modifiable contributors (sleep apnea, anemia, thyroid disease, depression, medications).
Core step for any chronic fatigue presentation to identify reversible drivers.
Use targeted labs and validated sleep/mood screens; avoid over-testing.
Energy conservation and pacing
Moderate EvidenceReduces flare-ups and optimizes function with limited energy reserves.
Prevents post-exertional worsening in chronic fatigue states.
Individualize; avoid rigid graded-exercise mandates in those with post-exertional symptom exacerbation.
Tailored exercise/physical rehabilitation
Moderate EvidenceAerobic and resistance training improve fatigue, mobility, and quality of life in MS when adapted to disability and heat sensitivity.
Improves fitness and reduces deconditioning-related fatigue in many chronic fatigue cases.
For patients meeting ME/CFS criteria, avoid fixed graded exercise; adopt pacing-first, symptom-titrated activity.
Cognitive-behavioral therapy (CBT) and CBT-I
Moderate EvidenceCBT modalities show small-to-moderate improvements in MS fatigue; CBT-I improves sleep and daytime energy.
Effective for insomnia and coping with chronic fatigue across conditions.
Not a cure; best combined with biomedical management.
Sleep optimization and treatment of sleep apnea
Strong EvidenceReduces daytime sleepiness and fatigue burden.
CPAP and sleep hygiene improve fatigue when sleep-disordered breathing or insomnia underlie symptoms.
Ensure adherence and mask fit; combine with weight, nasal, or positional strategies as needed.
Cooling strategies and heat management
Moderate EvidenceMitigates Uhthoff’s phenomenon and activity-related fatigue.
Heat can worsen nonspecific fatigue; cooling may improve tolerance to activity.
Monitor for over-cooling or skin issues.
Amantadine (trial)
Emerging ResearchCommonly used; may provide modest benefit for MS fatigue in some individuals.
Occasionally used off-label for refractory central fatigue of other etiologies.
Mixed evidence; assess response after 2–4 weeks; monitor insomnia, livedo reticularis.
Modafinil or methylphenidate (select cases)
Emerging ResearchEvidence mixed/low-certainty for MS fatigue; may help attention or sleepiness in comorbid disorders.
Can reduce excessive sleepiness; effect on fatigue variable.
Consider cardiovascular risk, anxiety, and sleep disruption; avoid in uncontrolled hypertension/arrhythmias.
Vitamin D repletion (if low)
Emerging ResearchImportant for overall MS care; uncertain direct effect on fatigue.
May improve well-being if deficient; evidence for fatigue is limited.
Check levels; avoid hypercalcemia with high-dose use.
Medical Perspectives
Two Ways of Seeing Health
Western
scientific · clinical
Western medicine applies science, technology, and clinical experience to treat symptoms through testing, diagnosis, and targeted intervention.
Surgeons · Pharmaceuticals · Clinical trials · Diagnostics 
Eastern
traditional · alternative
Eastern medicine focuses on treating the body naturally by applying traditional knowledge practiced for thousands of years, emphasizing balance and whole-person wellness.
Acupuncture · Herbal medicine · Yoga · Meditation
Gold Bamboo presents both perspectives side-by-side so you can make informed decisions. We don't advocate for one over the other — your health choices are yours.
Two Ways of Seeing Health
Western
scientific · clinical
Western medicine applies science, technology, and clinical experience to treat symptoms through testing, diagnosis, and targeted intervention.
Eastern
traditional · alternative
Eastern medicine focuses on treating the body naturally by applying traditional knowledge practiced for thousands of years, emphasizing balance and whole-person wellness.
Gold Bamboo presents both perspectives side-by-side so you can make informed decisions. We don't advocate for one over the other — your health choices are yours.
Western Perspective
In Western medicine, fatigue in MS is conceptualized as a multifactorial symptom arising from central mechanisms (neuroinflammation, demyelination, network inefficiency, autonomic and neuroendocrine changes) and secondary contributors (sleep disorders, mood, medications, pain, deconditioning, heat). Best practice is a stepped, biopsychosocial approach: systematically exclude and treat secondary causes; implement nonpharmacologic strategies with the strongest evidence; and consider time-limited pharmacologic trials for persistent, disabling fatigue.
Key Insights
- Fatigue is among the most prevalent and disabling MS symptoms and often exceeds physical disability in its impact.
- Central neuroinflammatory mechanisms and network disruption drive primary fatigue; secondary factors are common and treatable.
- Exercise/rehabilitation, CBT/CBT-I, energy conservation, and cooling have the best evidence-to-risk profile.
- Pharmacologic agents have modest and inconsistent benefit; trial carefully and discontinue if ineffective.
- Screening for sleep apnea, insomnia, depression/anxiety, thyroid and hematinic deficiencies prevents missed reversible causes.
Treatments
- Assessment and correction of secondary causes
- Energy conservation and pacing
- Adapted aerobic/resistance training and physiotherapy
- CBT and CBT-I; occupational therapy
- Cooling vests/devices; temperature planning
- Amantadine trial; consider modafinil or methylphenidate selectively
- Vitamin D repletion if deficient; smoking cessation
Deep Dive
From a Western perspective, fatigue in multiple sclerosis is a prototypical multifactorial symptom with both central and secondary drivers. Cent... From a Western perspective, fatigue in multiple sclerosis is a prototypical multifactorial symptom with both central and secondary drivers. Central mechanisms include neuroinflammation, demyelination, axonal loss, impaired network efficiency, and autonomic and neuroendocrine changes that heighten effort perception and reduce cognitive/physical stamina. Simultaneously, secondary factors—sleep disorders (apnea, insomnia), mood disturbances, pain and spasticity, bladder dysfunction causing nocturia, medication side effects, deconditioning, and environmental heat—compound fatigue. Because these elements frequently coexist, effective management requires a systematic, layered plan. First, clinicians should screen for and treat reversible contributors: sleep studies for suspected apnea or restless legs; targeted labs for thyroid dysfunction and iron/B12 deficiency; review and rationalize sedating medications; screen and treat depression/anxiety; address pain and spasticity; and implement bladder strategies to reduce nocturia. Second, nonpharmacologic therapies form the backbone: individualized energy conservation and pacing; symptom-titrated aerobic and resistance exercise or physiotherapy (with attention to heat sensitivity); occupational therapy to optimize task efficiency; CBT to improve coping and reduce fatigue impact; and CBT for insomnia to consolidate sleep. Cooling strategies (vests, pre-cooling, temperature planning) can mitigate heat-related worsening. Pharmacologic options—amantadine first-line in many practices, with modafinil or methylphenidate considered case-by-case—are reasonable time-limited trials after nonpharmacologic foundations are in place, with continuation only if meaningful benefit emerges. Vitamin D repletion when deficient and smoking cessation support overall MS care. This integrated approach, anchored in regular reassessment and shared decision-making, offers the best chance to reduce fatigue severity and restore participation in daily life.
Sources
- NICE Guideline CG186: Multiple sclerosis in adults—management (2014, updates).
- ECTRIMS/EAN guideline on symptomatic therapy in MS (2018).
- Cochrane Reviews: Pharmacologic and non-pharmacologic treatments for MS fatigue (various years).
- Penner IK, Paul F. Nat Rev Neurol. 2017.
Eastern Perspective
Eastern traditions interpret MS-like presentations and chronic fatigue through dysregulation of vital energy, organ systems, and mind–body balance. In Traditional Chinese Medicine (TCM), chronic fatigue is often viewed as Spleen and Kidney Qi deficiency with Dampness/Phlegm and possible Blood deficiency; MS overlaps with ‘Wei (atrophy) syndrome.’ Ayurveda frames MS within Vata–Kapha imbalance with depletion of Ojas (vital essence) and aggravated ‘Vata’ affecting nerve tissue (Majja Dhatu). Approaches emphasize restoring vitality and balance via acupuncture, herbal tonics/rasayana, diet, gentle movement (qigong, tai chi, yoga), and breath practices, generally combined with rest–activity pacing.
Key Insights
- Gentle, regular mind–body practices (yoga, tai chi, qigong) can improve fatigue, mood, and function in MS with low risk.
- Acupuncture may help fatigue and sleep in some individuals, though MS-specific evidence is limited.
- Herbal adaptogens/tonics (e.g., ginseng, astragalus; ashwagandha) are traditionally used for fatigue, but high-quality MS data are sparse; interactions and autoimmune effects require caution.
- Dietary patterns emphasizing warm, digestible foods (TCM) or Vata-pacifying, anti-inflammatory diets (Ayurveda) may support energy and digestion, with indirect fatigue benefits.
Treatments
- Yoga and pranayama; tai chi/qigong (2–4 sessions/week, symptom-titrated)
- Acupuncture focusing on tonifying and calming protocols (e.g., ST36, SP6, KI3, GV20; individualized)
- Herbal options with clinician oversight: TCM tonics (e.g., Huang Qi/astragalus, Ren Shen/ginseng) or Ayurvedic rasayana (e.g., ashwagandha)
- Mindfulness/meditation for stress and sleep regulation
- Dietary adjustments to reduce Dampness (TCM) or pacify Vata/Kapha (Ayurveda)
Deep Dive
Eastern medicine frames MS-like conditions and chronic fatigue as disturbances in vital energy and systemic balance. In Traditional Chinese Medi... Eastern medicine frames MS-like conditions and chronic fatigue as disturbances in vital energy and systemic balance. In Traditional Chinese Medicine, patterns such as Spleen and Kidney Qi deficiency with Dampness/Phlegm can manifest as heaviness, weakness, and fatigability; MS aligns with ‘Wei syndrome’ (atrophy), where nourishing Qi and Blood and resolving Dampness are therapeutic priorities. Ayurveda views MS through Vata–Kapha imbalance with depletion of Ojas, impairing resilience and nervous system integrity. Therapeutic aims center on restoring vitality, calming the nervous system, and optimizing digestion and sleep. Low-risk, mind–body modalities—yoga, tai chi, and qigong—are supported by small trials showing improvements in fatigue and mood for people with MS. Acupuncture protocols that tonify and calm (e.g., ST36, SP6, KI3, GV20) are used clinically for fatigue; evidence specific to MS is limited but promising for subjective symptoms in some patients. Herbal tonics/adaptogens such as ginseng or astragalus (TCM) and ashwagandha (Ayurveda) are traditionally employed to enhance stamina; however, rigorous MS-specific data are sparse, and potential herb–drug interactions or immune effects necessitate clinician oversight. Dietary strategies—warm, easily digestible meals in TCM; Vata-pacifying, anti-inflammatory foods in Ayurveda—may indirectly reduce fatigue by supporting sleep, mood, and gastrointestinal function. Integrating these practices with evidence-based Western care, and tailoring intensity through pacing to avoid post-exertional symptom flares, can offer a comprehensive, person-centered fatigue management plan.
Sources
- Oken BS et al. Yoga for MS: randomized controlled trial. Neurology. 2004.
- MS Society UK. Complementary and alternative therapies (accessed 2024).
- Cochrane reviews on acupuncture and Chinese herbal medicine for MS—evidence insufficient/inconclusive.
Evidence Ratings
Fatigue affects the majority of people with MS and is often disabling.
National MS Society; Penner & Paul, Nat Rev Neurol 2017.
Treating secondary contributors (sleep disorders, mood, endocrine/hematinic issues, medications) reduces fatigue burden.
NICE CG186; MS Society guidance.
Adapted exercise/rehabilitation improves MS-related fatigue.
Cochrane Review on exercise therapy for MS fatigue.
CBT and CBT-I yield small-to-moderate improvements in fatigue and sleep in MS.
Cochrane/nonpharmacologic reviews in MS fatigue.
Amantadine provides at most modest benefit for MS fatigue; evidence quality is low to moderate.
Cochrane pharmacologic review for MS fatigue.
Modafinil/methylphenidate have inconsistent benefits for MS fatigue.
Cochrane pharmacologic review; ECTRIMS/EAN guidance.
Cooling strategies reduce heat-related symptom worsening and perceived fatigue in MS.
MS Society guidance; small controlled studies.
Yoga and similar mind–body practices can improve fatigue and mood in MS.
Oken et al., Neurology 2004; subsequent small trials.
Acupuncture/herbal medicine may help subjective fatigue, but MS-specific evidence is insufficient.
Cochrane reviews of acupuncture/TCM in MS—insufficient evidence.
EBV is a major risk factor for MS; viral illnesses can be associated with prolonged fatigue.
Bjornevik et al., Science 2022; general post-viral fatigue literature.
Sources
- National Multiple Sclerosis Society. Fatigue. https://www.nationalmssociety.org/Symptoms-Diagnosis/MS-Symptoms/Fatigue
- MS Society UK. Fatigue. https://www.mssociety.org.uk/about-ms/signs-and-symptoms/fatigue
- NICE Guideline CG186. Multiple sclerosis in adults: management. https://www.nice.org.uk/guidance/cg186
- ECTRIMS/EAN Guideline on the pharmacological treatment of symptoms of multiple sclerosis. Eur J Neurol. 2018.
- Penner IK, Paul F. Fatigue in multiple sclerosis: pathophysiology and management. Nat Rev Neurol. 2017;13(11):662-675.
- Cochrane Review: Exercise therapy for fatigue in multiple sclerosis. (latest update cited in Cochrane Library).
- Cochrane Review: Pharmacologic treatments (amantadine, modafinil, pemoline) for MS-related fatigue. (Cochrane Library).
- Oken BS et al. Randomized controlled trial of yoga in MS. Neurology. 2004;62:2058-2064.
- Bjornevik K et al. Longitudinal analysis reveals EBV as a leading cause of MS. Science. 2022;375(6578):296-301.
- Veauthier C. Sleep disorders in multiple sclerosis. Curr Neurol Neurosci Rep. 2015.
Related Topics
Recommended Products
Multiple Sclerosis: A Guide for the Newly Diagnosed
Amazon.com: Multiple Sclerosis: A Guide for the Newly Diagnosed: 9781888799064: Holland, Nancy J.; Murray, T. Jock; Reingold, Stephen C.; Murray, T.J.: Books
Polar Products Fashion Cooling Vest for Men and Women with Kool Max Packs or Cool58 Phase Change Cooling Packs (Cool58, Womens-Khaki, X-Small)
It takes more energy to charge ... 58 Phase Change Cooling Packs <strong>fully charge (freeze) at 58ºF (14.4°C) and provide a comfortable, constant cooling temperature of 58ºF for up to 2 to 3 hours</
Jarrow Formulas® Acetyl L-Carnitine 500 mg, Dietary Supplement, Amino Acid Support for Brain Health and Antioxidants, 120 Veggie Capsules, 120 Day Supply
Veggie Capsules - <strong>Each capsule delivers 500 mg of acetyl l-carnitine</strong>. Adults take 1 capsule once or twice per day on an empty stomach, or as directed by your qualified healthcare prof
Health Disclaimer
This content is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before starting, stopping, or changing any supplement or medication regimen.